跳至主要内容
临床试验/NCT02001779
NCT02001779已完成不适用

Study of Stent Insertion Combined With or Without Brachytherapy in Patients With Inoperable Malignant Biliary Obstruction

Zhongda Hospital1 个研究点 分布在 1 个国家目标入组 328 人开始时间: 2013年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
328
试验地点
1
主要终点
Patency

研究概览

简要总结

Stenting the malignant biliary obstruction is considered to be the preferred palliation modality to relieve pruritus,cholangitis,pain and jaundice in patients without surgical indications of malignant biliary obstruction.An unicentral clinical trial has demonstrated the safety and technical feasibility of an irradiation biliary stent insertion in patients with biliary obstruction caused by adenocarcinomas, such a treatment seems have benefits in relieving jaundice and extending survival when compared to a conventional biliary stent.However,the small sample size,the population distribution of two groups will influence the final results in obtaining a powerful statistical conclusion.Therefore,a multicentric study was designed to prospectively compared the responses to the treatment with this irradiation biliary stent versus the conventional biliary self-expandable stent in patients with inoperable malignant biliary obstruction.

详细描述

Malignant biliary obstruction is a common condition caused by various carcinomas.The clinical process is usually silent and insidious,only 10-20% patients can be surgically removed once obstructive jaundice occurred.The long-term survival rate after resection remain dismal.Relief of obstructive jaundice plays major role on prognosis in patients without surgical indications.For unresectable patients,stenting the biliary obstruction is considered to be the preferred palliation modality to relieve pruritus,cholangitis,pain and jaundice.Although a number of new techniques for treatment of malignant biliary obstruction have been developed,there have been no significant differences in survival or quality of life comparing surgery bypass versus plastic stent insertion,metal stent insertion versus plastic stents insertion,or covered stent versus uncovered stents insertion in such patients.Our previous unicentric clinical trial has demonstrated the safety and technical feasibility of a biliary intraluminal irradiation stent insertion in patients with biliary obstruction caused by adenocarcinomas, such a treatment seems have benefits in relieving jaundice and extending survival when compared to a conventional biliary stent.However,the small sample size,the population distribution of two groups will influence the final results in obtaining a powerful statistical conclusion in the overall survival and stent patency between two groups.Therefore,a multicentric study was designed to prospectively compared the responses to the treatment with this irradiation biliary stent versus the conventional biliary self-expandable stent in patients with inoperable malignant biliary obstruction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical,histological or pathological diagnosis of malignant biliary obstruction
  • Unresectability or refusal to be surgically treated
  • The Eastern Cooperative Oncology Group(ECOG) scores from 0 to 3
  • With symptoms such as jaundice related to biliary obstruction
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study
  • Biliary obstruction of Bismuthe-Corlette,type I and II

排除标准

  • Benign biliary obstruction
  • The Eastern Cooperative Oncology Group(ECOG) score of 4
  • Biliary tract stricture that could not be dilated enough to pass the delivery system
  • Presence of metallic biliary stent or bile duct surgery
  • Percutaneous transhepatic cholangiography(PTC) procedure was contraindicated
  • Active hepatitis
  • Biliary obstruction of Bismuthe-Corlette,type Ⅲ and Ⅳ
  • Uncooperative or could not provide authorization and signature

结局指标

主要结局

Patency

时间窗: Participants will be followed till die or lost to follow-up,an expected average of a year.

Time from stenting to the day when stricture/obstruction of the stent occured or restricture/reobstruction after recanalization the obstructed stent.

次要结局

  • Clinical success(Participants will be followed till die or lost to follow-up,an expected average of a year.)
  • Over survival(Participants will be followed till die or lost to follow-up,an expected average of a year.)
  • Safety(Participants will be followed till die or lost to follow-up,an expected average of a year.)

研究者

发起方
Zhongda Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gao-jun Teng

Professor of Radiology & Chair,Department of Radiology

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验